TEEM-GIFTS: a Gamified MHealth to Reduce Post-Discharge Suicide Risk
Launched by SHENZHEN KANGNING HOSPITAL · Apr 7, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The TEEM-GIFTS trial is studying a new mobile health program designed to help reduce the risk of suicide in patients with mental health disorders after they leave the hospital. This program will use fun, game-like features to encourage patients to stay engaged with their treatment and follow-up care. Researchers believe that this approach can make it easier for patients to stay on track with their mental health, especially since there are currently not enough services available in the community to support them after discharge.
To participate in this trial, individuals must be at least 18 years old and have been diagnosed with a mental health disorder, having stayed in the hospital for three or more days. They should also live in Shenzhen and be able to use smartphone apps like WeChat. The study will involve patients, their family supporters, and mental health service providers who will work together to improve care and reduce suicide risk. Participants can expect to engage with the mobile program and contribute to research that could improve mental health support in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For patients
- • Being 18 years and above;
- • Being diagnosed with mental disorders;
- • Having received inpatient care for three days or more;
- • Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- • Being able to use apps or WeChat (WeChat mini program) on smart phones.
- • For lay health care supporters (LHSs)
- • Being 18 years and above;
- • Being without any diagnosis of mental disorder;
- • Being the lay health care supporter in the family;
- • Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- • Being able to use apps or WeChat (WeChat mini program) on smart phones.
- • For the clinic and community mental health service providers
- • Being 18 years and above;
- • Having practiced in mental health service at least for 12 months.
- • Exclusion criteria For patients
- • Refusing to provide written consent or be unable to provide written consent due to any cognitive problems.
- • Being discharged by the patient's or LHSs' demand against medical advice.
- • With no ID, no stable residence nor any source of income.
- • For For lay health care supporters (LHSs)
- • Refusing to provide written consent.
- • For the clinic and community mental health service providers
- • Refusing to provide written consent.
About Shenzhen Kangning Hospital
Shenzhen Kangning Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Shenzhen, China, the hospital specializes in mental health and neurological disorders, offering comprehensive services that integrate patient care with groundbreaking scientific inquiry. With a commitment to improving treatment outcomes, Shenzhen Kangning Hospital collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials that adhere to the highest ethical standards and regulatory guidelines. Its state-of-the-art facilities and multidisciplinary approach ensure a robust environment for both patient safety and the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Trial Officials
Fengsu Hou, Ph.D.
Principal Investigator
Shenzhen Kangning Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported